about
Locking plate fixation of distal femoral fractures is a challenging technique: a retrospective reviewBack pain-related disability and quality of life in patients affected by vertebral fractures: data from baseline characteristics of population enrolled in Denosumab In Real Practice (DIRP).Hip fracture in Italy: analysis of DRG data.Bone quality and bone strength: benefits of the bone-forming approach.Ten years of hip fractures in Italy: For the first time a decreasing trend in elderly women.Risedronate's efficacy: from randomized clinical trials to real clinical practice.Pharmaco-economic issues in the treatment of severe osteoporosisPhysical exercise and sarcopenia in older people: position paper of the Italian Society of Orthopaedics and Medicine (OrtoMed)Neuropsychiatric disorders in hip fractureManagement of atypical femoral fracture: a scoping review and comprehensive algorithm.Effectiveness of teriparatide treatment on back pain-related functional limitations in individuals affected by severe osteoporosis: a prospective pilot study.Rehabilitation in esophageal cancer.Algodystrophy in major orthopaedic surgery.The contribution of cortical and trabecular tissues to bone strength: insights from denosumab studiesEvaluation of persistence and adherence to teriparatide treatment in patients affected by severe osteoporosis (PATT): a multicenter observational real life study.Painful prosthesis: approaching the patient with persistent pain following total hip and knee arthroplasty.Incidence of breast cancer in Italy: mastectomies and quadrantectomies performed between 2000 and 2005Rates and reasons for lack of persistence with anti-osteoporotic drugs: analysis of the Campania region database.Osteoporosis and cardiovascular diseases' cosegregation: epidemiological features.Vitamin D supplementation in fractured patient: how, when and why.Diabetes and Obesity as Independent Risk Factors for Osteoporosis: Updated Results from the ROIS/EMEROS Registry in a Population of Five Thousand Post-Menopausal Women Living in a Region Characterized by Heavy Environmental Pressure.Prevention of falls and role of calcium and vitamin D.Inhibition of RANK ligand: a new option for preventing fragility fractures.Bone healing and osteoporosis.Mechanobiology of bone.A new antiresorptive approach to the treatment of fragility fractures: long-term efficacy and safety of denosumab.Effects of denosumab on cortical and trabecular microarchitecture: evidences from clinical studies.Post-surgical rehabilitative approach to fragility fractures.Management of bone disease in Gaucher disease type 1: clinical practice.Neridronate improves bone mineral density and reduces back pain in β-thalassaemia patients with osteoporosis: results from a phase 2, randomized, parallel-arm, open-label study.Can vitamin D deficiency influence muscle performance in post-menopausal women? A multicenter retrospective study.Persistence with denosumab therapy in women affected by osteoporosis with fragility fractures: a multicenter observational real practice study in Italy.Complex regional pain syndrome (CRPS) type I: historical perspective and critical issues.Treatment of complex regional pain syndrome.Prescription of anti-osteoporosis medications after hospitalization for hip fracture: a multicentre Italian survey.Are Dietary Supplements and Nutraceuticals Effective for Musculoskeletal Health and Cognitive Function? A Scoping Review.Prevalent fragility fractures as risk factor for skeletal muscle function deficit and dysmobility syndrome in post-menopausal women.Bone involvement in males with Kallmann disease.Hypovitaminosis D is associated with a reduction in upper and lower limb muscle strength and physical performance in post-menopausal women: a retrospective study.Proximal femur geometry assessed by hip structural analysis in hip fracture in women.
P50
Q28081419-EAEAF431-0464-43D7-81B4-DD11E6397C98Q30982610-57E87290-1695-44DB-B647-28D627D82977Q31142204-3880A04D-A135-4CED-859F-17E30EE2CEABQ33781595-620A64C0-B425-458E-9C3A-27C52A7CD38EQ33891994-C77B19B9-2049-4A4A-B5DC-0DE9F23FE6FFQ33965652-E315330F-4938-406C-B481-23057AD2D713Q33965701-C99F13BF-8A5F-43F1-A8D3-DEB2A4ACF918Q34722319-3983CBB0-82C4-45DC-9C77-589E03996FA1Q35755666-8296ED8A-4216-488E-AE5E-20A750F880A8Q36027214-8A4B29F2-1A03-4D5E-B7E7-B8B84F4061C3Q36505604-DA9DDC0E-399D-4986-B895-A31CD3FE6A4CQ36515118-D14FC9E9-6F68-498D-9AC4-E5180324A17BQ36800205-B3EF59AF-74DE-4F54-A952-0636009C9DC4Q37008054-789151C2-C501-4273-99CD-4BDC874762D9Q37008062-5BC7CD3F-EE42-4BE7-B26F-C775DDF60FB8Q37230596-BD415C24-DA22-47C6-8B4F-CE58D79BFAB3Q37268370-15175738-A7F1-4E6A-A5BB-EC4A240ACB4BQ37429327-9164AAE3-F2FF-4EBF-9418-750089D0D496Q37430287-1F8BC0C9-68DB-4E84-9871-CDD80753C58DQ37430423-E1309BA6-0C15-43AA-9451-368F2F7A7F57Q37455580-E1822F5F-E8E1-4D40-BB74-9F2D786B657AQ37942302-CB8CF4B5-12D9-42CA-A00E-21166FD66CBFQ37942306-7D9E59B2-2338-4FE4-B8F9-1952D718FDE8Q37942319-4C5276AE-290E-445C-9AFE-087B46A694A7Q38138856-0BC8DA26-793E-4A77-9B6D-6E435FBE6E39Q38138862-B7F98AFE-4C53-4E4D-A237-2A0371F1BF60Q38138867-28CFD51D-391F-493B-9BB6-C2FB2ECDE0FCQ38138868-200AA127-97A5-462C-BF2B-61FA57BCF29CQ38290826-1849935C-080C-48FF-B9A3-350F4CF1E51DQ38471926-31EFD757-2C77-4381-81F8-D09102AF6865Q38684542-BEA56A9D-7714-4CE4-B5FF-F5A4879526C0Q38739204-F30DEF93-DAB6-474E-9E06-E447CC9B00A1Q38822720-38B75FF2-529F-4D17-8D0E-34030D209999Q38822728-52EEE3A7-C861-4763-93CF-8DDF49B2C630Q39109115-162F734E-4B0C-45E1-89A6-241C83A3E4C8Q39266649-50CEA79D-44B4-4AAE-BDE5-9049DFA322C7Q40703166-B4DA5095-42A9-4342-93E4-E04F16F7599AQ40706883-59D2945F-0C6E-4A42-912C-1BFB6CC66CBBQ40727118-62D9E5D4-F66E-4B23-A0D6-2779CC5E67F1Q40732563-04C47FC9-4A6D-4825-8CA0-CDEAF7D5FD35
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Giovanni Iolascon
@ast
Giovanni Iolascon
@en
Giovanni Iolascon
@es
Giovanni Iolascon
@nl
Giovanni Iolascon
@sl
type
label
Giovanni Iolascon
@ast
Giovanni Iolascon
@en
Giovanni Iolascon
@es
Giovanni Iolascon
@nl
Giovanni Iolascon
@sl
prefLabel
Giovanni Iolascon
@ast
Giovanni Iolascon
@en
Giovanni Iolascon
@es
Giovanni Iolascon
@nl
Giovanni Iolascon
@sl
P1053
T-6220-2017
P106
P1153
23667578000
P21
P31
P3829
P496
0000-0002-0976-925X